AZAD's complete network comprising a sales and marketing force, Swiss R&D facilities, and international production partners ensures cutting edge service in the development and supply of quality generic APIs and selected Finished Dosage Forms.
Partners - generic APIs
The company was founded in Schaffhausen in 1936 and joined The Johnson & Johnson Family of Companies in 1959. The J & J Family of Companies, with approximately 120’000 employees, is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and professional markets. Johnson & Johnson Family of Companies has 250 operating companies in 57 countries around the world, selling products in more than 175 countries.
YONSUNG Fine Chemicals Co. was founded in 2000. The company is a top quality, fast growing manufacturer of APIs, especially, PROSTAGLANDINS and related products for pharmaceutical applications.
Neuland is a leading Hyderabad based manufacturer of active pharmaceutical ingredients and an end-to-end solution provider for the pharmaceutical industry for chemistry related services. They are more than 1000 employees strong and their core competence lies in the application of strong process chemistry to manufacturing in regulatory environment.
Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) founded in 1964, is one of the largest API manufacturer in Taiwan, located in the suburb of Taipei. CCSB has developed more than 30 bulk pharmaceutical products.
Farmak's tradition of industrial chemical production began in 1934 and has been developed in the years since. Nowadays Farmak, a.s. (joint stock company) is a private, independent Czech company.
Polpharma is the largest manufacturer of drugs and active pharmaceutical ingredients in Poland. Polpharma's products are exported to over 50 countries of the world.
NerPharMa is a newly established company, operating since January 2010. Together with its sister company NerPharMa DS (dealing with manufacturing of API), it was created as a spin-off from Nerviano Medical Sciences, the largest, privately owned R&D facility in Italy.
Partners – Drug Products
HELP S.A. is a Pharmaceutical Company, established in 1971, engaged in the Research, Development, Manufacturing, Distribution and Commercialisation of high quality, prescription drug products. Their foundation and future growth lies in the development & manufacturing of generic products. Their manufacturing plant is located in the North of Greece.
Hikma was founded in 1978 in Amman (Jordan). Hikma has steadily evolved as a leading multinational pharmaceutical company, with a steadfast reputation for quality. The Com-pany’s initial focus was on developing a branded pharmaceuticals business across the MENA region. In the early 1990s, Hikma acquired a generic pharmaceuticals business in the United States and established an injectable pharmaceutical operation in Portugal, thereby expanding the Company’s outreach beyond the MENA region.
The Farmigea Istituto Chimico Farmaeutico Sperimentale was established in 1946 and be¬gan manufacturing. In the beginning the firm produced a wide range of generic products like health tonics in syrup form, extracts, dermatological creams, ointments and even its first eye-drops.Farmigea’s International Business Development Department has two main objectives: to increase export sales of its proprietary medicines and to enhance the international aware-ness of our proprietary medicines through a network of strategic alliances. Today Farmigea is present in over twenty countries throughout the world.
The Company’s roots stretch back to the Lisbon of 1949 and the founding of “Laboratório Medicamenta”. This small laboratory under went ongoing expansion resulting in a 1968 move to bigger and more modern facilities. In 1988, 39 years after its foundation, Medicamenta was bought out by Cilag. In 1995, the Belgiam Janssen company merged with Cilag leading to “Janssen-Cilag Pharmaceutical”: Believing in the potential of the Portuguese pharmaceuti¬cal industry, new cutting edge facilities were built in Queluz. In 2004, a group of Portuguese business entrepreneurs took over the Janssen-Cilag and thus did Lusomedica¬menta appear.
Established in 1949 in Greece, Famar is one of Europe’s leading providers of Contract Manufacturing and Development Services to the Pharmaceutical and Health & Beauty industry.
Established in 1978 in Korea, Taejoon is one of the leading opthalmics and contrast media companies in Korea. It is EU GMP certified and has a state of the art manufacturing including blow fill and seal technology.